Cargando…
The Effect of K(ATP) Channel Blocker Glibenclamide on CGRP-Induced Headache and Hemodynamic in Healthy Volunteers
BACKGROUND: Calcitonin gene-related peptide (CGRP) dilates cranial arteries and triggers headache. The CGRP signaling pathway is partly dependent on activation of ATP-sensitive potassium (K(ATP)) channels. Here, we investigated the effect of the K(ATP) channel blocker glibenclamide on CGRP-induced h...
Autores principales: | Coskun, Hande, Elbahi, Fatima Azzahra, Al-Karagholi, Mohammad Al-Mahdi, Ghanizada, Hashmat, Sheykhzade, Majid, Ashina, Messoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226177/ https://www.ncbi.nlm.nih.gov/pubmed/34177610 http://dx.doi.org/10.3389/fphys.2021.652136 |
Ejemplares similares
-
Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial
por: Pellesi, Lanfranco, et al.
Publicado: (2021) -
Glibenclamide Posttreatment Does Not Inhibit Levcromakalim Induced Headache in Healthy Participants: A Randomized Clinical Trial
por: Kokoti, Lili, et al.
Publicado: (2023) -
Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache
por: Ghanizada, Hashmat, et al.
Publicado: (2020) -
Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study
por: Pellesi, Lanfranco, et al.
Publicado: (2022) -
The role of high‐conductance calcium‐activated potassium channel in headache and migraine pathophysiology
por: Al‐Karagholi, Mohammad Al‐Mahdi, et al.
Publicado: (2022)